Therapeutics Projects

2013 Projects

Nanomaterials for Cell-based Therapies in Parkinson's Disease

Recent advances in stem cell biology, tissue engineering, and materials science have revived the hope for new therapeutic strategies in Parkinson's disease. Samuel Stupp’s group is currently developing an artificial extracellular matrix to address the challenges of finding a viable treatment.
Read More

VEGF-based Nanoparticles as a Therapy for Spinocerebellar Ataxia Type 1 (SCA1)

Motivated and inspired by current nanotechnology, Puneet Opal’s group will investigate the potential of using a synthetic VEGF peptide amphiphile (VEGF-PA) nano-peptide as an innovative and inexpensive alternative to recombinant VEGF for long-term therapy for cerebellar degenerations, such as Parkinson disease, Alzheimer disease, and motor neuron disorders.
Read More

CRN catalyzes new research in regenerative medicine using nanotechnology strategies.